Evidence map›Paper›PMID 41018014›Full record

ArticleData in brief2025

In silico binding role of flavonoids as SARS-CoV-2 main protease (M

Mariyam Eema, Vasudeva Rao Avupati

Abstract read
In one paragraph

Article in Data in brief, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mariyam EemaMSc in Molecular Medicine, School of Postgraduate Studies, IMU University, Kuala Lumpur 57000, Malaysia.
Vasudeva Rao AvupatiDepartment of Pharmaceutical Chemistry, School of Pharmacy, IMU University, Kuala Lumpur 57000, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Health Organization declared a global pandemic in March 2020, the virus has infected and killed millions of individuals worldwide without discrimination. Due to the lack of SARS-CoV-2-specific treatment options and rapidly mutating variants, the virus triggered waves of infection and death. Computer-assisted drug design techniques have allowed rapid virtual screening and molecular docking for the identification of numerous biological hit compounds. The Schrodinger glide software was used to perform high-throughput virtual screening on a database of 2055 flavonoid derivative compounds against the SARS-CoV-2 main protease 6LU7. The Glide Docking scores narrowed the database to ten hit molecules with the PubChem CIDs 1882879, 1866522, 941256, 5703289, 626515, 1974731, 654250, 5490127, 941927, and 5282073. Their scores ranged between -8.073, -7.981, -7.754, -7.933, -7.911, -7.903, -7.875, -7.854, -7.826, and -7.821 kcal/mol, respectively. They were also studied for their binding properties, including binding interactions, binding orientation and binding energies.

Indexed as

Flavonoids datasetHigh-throughput virtual screening (HTVS)Molecular dockingSARS-CoV-2 main protease (Mpro) inhibitors

Identifiers

PMID41018014
PMCPMC12461212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.